The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: A report of gender differences

European Neuropsychopharmacology

Volumn 23, Issue 8, 2013, Pages 910-918

  Bloch, Miki ^a,b   Meiboom, Hadas ^a   Zaig, Inbar ^a   Schreiber, Shaul ^a,b   Abramov, Liora ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Arousal; Dehyroepiandrosterone; Gender; Hypoactive sexual desire disorder; Neurosteroids; Testosterone

Indexed keywords

ANDROSTERONE; PLACEBO; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ACNE; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG USE; ESTRADIOL BLOOD LEVEL; FATIGUE; FEMALE; HOT FLUSH; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; LIBIDO; MALE; MEDICATION COMPLIANCE; ORGASM; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SEXUAL AROUSAL; SEXUAL FUNCTION; SEXUAL SATISFACTION; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION;

AROUSAL; DEHYROEPIANDROSTERONE; GENDER; HYPOACTIVE SEXUAL DESIRE DISORDER; NEUROSTEROIDS; TESTOSTERONE;

ADULT; AGED; ANDROSTERONE; BIOTRANSFORMATION; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE-BLIND METHOD; DRUG RESISTANCE; ESTRADIOL; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; NEUROTRANSMITTER AGENTS; POSTMENOPAUSE; SEX CHARACTERISTICS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TESTOSTERONE;

EID: 84881664918     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.09.004     Document Type: Article

References (52)

1. American Psychiatric Association (APA), 2000. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th ed., text rev. Washington, DC.
2. Arlt, W., Callies, F., van Vlijmen, J.C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H.M., Allolio, B., 1999. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N. Engl. J. Med. 341, 1013-1020.
3. Arlt W., Justl H.-G., Callies F., Reincke M., Hübler D., Oettel M., Ernst M., Schulte H.M., Allolio B. Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression. J. Clin. Endocrinol. Metabol. 1998, 83:1928-1934.
4. Basson R., Leiblum S., Brotto L., Derogatis L., Fourcroy J., Fugl-Meyer K., Graziottin A., Heiman J.R., Laan E., Meston C., Schover L., van Lankveld J., Schultz W.W. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J. Psychosom. Obst. Gynecol. 2003, 24:221-229.
5. Baulieu E.-E., Thomas G., Legrain S., Lahlou N., Roger M., Debuire B., Faucounau V., Girard L., Hervy M.-P., Latour F., Leaud M.-C., Mokrane A., Pitti-Ferrandi H., Trivalle C., de Lacharrière O., Nouveau S., Rakoto-Arison B., Souberbielle J.-C., Raison J., Le Bouc Y., Raynaud A., Girerd X., Forette F. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue. Proc. Natl. Acad. Sci. 2000, 97:4279-4284.
6. Bloch M., Rubinow D.R., Berlin K., Kevala K.R., Kim H.-Y., Schmidt P.J. Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men. Arch. Gen. Psychiatry 2006, 63:450-456.
7. Bloch M., Schmidt P.J., Danaceau M.A., Adams L.F., Rubinow D.R. Dehydroepiandrosterone treatment of midlife dysthymia. Biol. Psychiatry 1999, 45:1533-1541.
8. Braunstein G.D., Sundwall D.A., Katz M., Shifren J.L., Buster J.E., Simon J.A., Bachman G., Aguirre O.A., Lucas J.D., Rodenberg C., Buch A., Watts N.B. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch. Intern. Med. 2005, 165:1582-1589.
9. Brotto L.A. The DSM diagnostic criteria for hypoactive sexual desire disorder in men. J. Sex Med. 2010, 7:2015-2030.
10. Brotto L.A., Bitzer J., Laan E., Leiblum S., Luria M. Women's sexual desire and arousal disorders. J. Sex Med. 2010, 7:586-614.
11. Buvat J., Maggi M., Gooren L., Guay A.T., Kaufman J., Morgentaler A., Schulman C., Tan H.M., Torres L.O., Yassin A., Zitzmann M. Endocrine aspects of male sexual dysfunctions. J. Sex Med. 2010, 7:1627-1656.
12. Clayton A.H. The pathophysiology of hypoactive sexual desire disorder in women. Int. J. Gynecol. Obst. 2010, 110:7-11.
13. Clayton A.H., Clavet G.J., McGarvey E.L., Warnock J.K., Weiss K. Assessment of sexual functioning during the menstrual cycle. J. Sex Marital Ther. 1999, 25:281-291.
14. Davis S.R., Davison S.L., Donath S., Bell R.J. Circulating androgen levels and self-reported sexual function in women. JAMA J. Am. Med. Assoc. 2005, 294:91-96.
15. Davis S.R., Moreau M., Kroll R., Bouchard C., Panay N., Gass M., Braunstein G.D., Hirschberg A.L., Rodenberg C., Pack S., Koch H., Moufarege A., Studd J. Testosterone for low libido in postmenopausal women not taking estrogen. N. Engl. J. Med. 2008, 359:2005-2017.
16. Davison S.L., Bell R., Donath S., Montalto J.G., Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 2005, 90:3847-3853.
17. Dennerstein L., Koochaki P., Barton I., Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of western European women. J. Sex Med. 2006, 3:212-222.
18. DeRogatis L., Rosen R.C., Goldstein I., Werneburg B., Kempthorne-Rawson J., Sand M. Characterization of hypoactive sexual desire disorder (HSDD) in men. J. Sex Med. 2012, 9:812-820.
19. Derogatis L.R. The derogatis interview for sexual functioning (DISF/DISF-SR): an introductory report. J. Sex Marital. Ther. 1997, 23:291-304.
20. Genazzani A.R., Stomati M., Valentino V., Pluchino N., Potì E., Casarosa E., Merlini S., Giannini A., Luisi M. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality. Climacteric 2011, 14:661-668.
21. Hackbert L., Heiman J.R. Acute dehydroepiandrosterone (DHEA) effects on sexual arousal in postmenopausal women. J. Womens Health Gend. Based Med. 2002, 11:155-162.
22. Johannsson G., Burman P., Wirén L., Engström B.E., Nilsson A.G., Ottosson M., Jonsson B., Bengtsson B.-Å., Karlsson F.A. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J. Clin. Endocrinol. Metab. 2002, 87:2046-2052.
23. Kancheva R., Hill M., Novák Z., Chrastina J., Kancheva L., Stárka L. Neuroactive steroids in periphery and cerebrospinal fluid. Neuroscience 2011, 191:22-27.
24. Kritz-Silverstein D., Von Mühlen D., Laughlin G.A., Bettencourt R. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial. J. Am. Geriatr. Soc. 2008, 56:1292-1298.
25. Labrie F. DHEA: important source of sex steroids in men and even more in women. Progress in Brain Research 2010, 97-148. Elsevier, (Chapter 4). M. Luciano (Ed.).
26. Labrie F., Bélanger A., Bélanger P., Bérubé R., Martel C., Cusan L., Gomez J., Candas B., Chaussade V., Castiel I., Deloche C., Leclaire J. Metabolism of DHEA in postmenopausal women following percutaneous administration. J. Steroid Biochem. Mol. Biol. 2007, 103:178-188.
27. Laumann E.O., Paik A., Rosen R.C. Sexual dysfunction in the United States. JAMA J. Am. Med. Assoc. 1999, 281:537-544.
28. Lingjærde O., Ahlfors U.G., Bech P., Dencker S.J., Elgen K. The UKU side effect rating scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr. Scand. 1987, 76:1-100.
29. Morales A., Black A., Emerson L., Barkin J., Kuzmarov I., Day A. Androgens and sexual function: a placebo-controlled, randomized, double-blind study of testosterone vs. dehydroepiandrosterone in men with sexual dysfunction and androgen deficiency. Aging Male 2009, 12:104-112.
30. Morales A.J., Haubrich R.H., Hwang J.Y., Asakura H., Yen S.S.C. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clin. Endocrinol. (Oxf) 1998, 49:421-432.
31. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 1994, 78:1360-1367.
32. Munarriz R., Talakoub L., Flaherty E., Gioia M., Hoag L., Kim N.N., Traish A., Goldstein I., Guay A., Spark R. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results. J. Sex Marital Ther. 2002, 28:165-173.
33. Panjari M., Bell R.J., Jane F., Wolfe R., Adams J., Morrow C., Davis S.R. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido. J. Sex Med. 2009, 6:2579-2590.
34. Panjari M., Davis S.R. DHEA therapy for women: effect on sexual function and wellbeing. Hum. Reprod. Update 2007, 13:239-248.
35. Rabkin J.G., Ferrando S.J., Wagner G.J., Rabkin R. DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters. Psychoneuroendocrinology 2000, 25:53-68.
36. Rosen R., Brown C., Heiman J., Leiblum S., Meston C., Shabsigh R., Ferguson D., D'Agostino R. The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J. Sex Marital Ther. 2000, 26:191-208.
37. Rubinow D.R., Schmidt P.J. Androgens, brain, and behavior. Am. J. Psychiatry 1996, 153:974-984.
38. Schmidt P.J., Berlin K.L., Danaceau M.A., Neeren A., Haq N.A., Roca C.A., Rubinow D.R. The effects of pharmacologically induced hypogonadism on mood in healthy men. Arch. Gen. Psychiatry 2004, 61:997-1004.
39. Schmidt P.J., Daly R.C., Bloch M., Smith M.J., Danaceau M.A., Simpson St.Clair L., Murphy J.H., Haq N., Rubinow D.R. Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Arch. Gen. Psychiatry 2005, 62:154-162.
40. Shalev, A.Y., Abramowitz, M.Z., Kaplan-De-Nour, A., 1994. Structured Clinical Interview for DSM-IV Patient Edition (SCID-I/P, Version 2.0; Hebrew Version, 1994). Center for Traumatic Stress, Department of Psychiatry, Hadassah University Hospital, Jerusalem, Israel.
41. Shifren J.L., Braunstein G.D., Simon J.A., Casson P.R., Buster J.E., Redmond G.P., Burki R.E., Ginsburg E.S., Rosen R.C., Leiblum S.R., Caramelli K.E., Jones K.P., Daugherty C.A., Mazer N.A. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N. Engl. J. Med. 2000, 343:682-688.
42. Shifren J.L., Davis S.R., Moreau M., Waldbaum A., Bouchard C., DeRogatis L., Derzko C., Bearnson P., Kakos N., O'Neill S., Levine S., Wekselman K., Buch A., Rodenberg C., Kroll R. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause 2006, 13:770-779.
43. Shifren J.L., Monz B.U., Russo P.A., Segreti A., Johannes C.B. Sexual problems and distress in United States women: prevalence and correlates. Obstet. Gynecol. 2008, 112:970-978.
44. Simon J., Braunstein G., Nachtigall L., Utian W., Katz M., Miller S., Waldbaum A., Bouchard C., Derzko C., Buch A., Rodenberg C., Lucas J., Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J. Clin. Endocrinol. Metab. 2005, 90:5226-5233.
45. Strous R.D., Maayan R., Weizman A. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Eur. Neuropsychopharmacol. 2006, 16:155-169.
46. Turna B., Apaydin E., Semerci B., Altay B., Cikili N., Nazli O. Women with low libido: correlation of decreased androgen levels with female sexual function index. Int. J. Impot. Res. 2005, 17:148-153.
47. Veit C.T., Ware J.E. The structure of psychological distress and well-being in general populations. J. Consult. Clin. Psychol. 1983, 51:730-742.
48. Wang C., Swerdloff R.S., Iranmanesh A., Dobs A., Snyder P.J., Cunningham G., Matsumoto A.M., Weber T., Berman the Testosterone Gel Study Group N. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J. Clin. Endocrinol. Metab. 2000, 85:2839-2853.
49. Warnock J.J. Female hypoactive sexual desire disorder: epidemiology, diagnosis and treatment. CNS Drugs 2002, 16:745-753.
50. Waxenberg S.E., Finkbeiner J.A., Drellich M.G., Sutherland A.M. The role of hormones in human behavior: II. Changes in sexual behavior in relation to vaginal smears of breast-cancer patients after oophorectomy and adrenalectomy. Psychosom. Med. 1960, 22:435-442.
51. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry 1999, 156:646-649.
52. Zheng P. Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance. Prog. Neurobiol. 2009, 89:134-152.